Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study
Hiroyuki Murai(Kyushu University), Luiz Augusto da Silva, David Feder, Renata Martins Ribeiro, Kimiaki Utsugisawa(National Hospital Organization Hanamaki Hospital), Alzira Alves de Siqueira Carvalho(Centro Universitário Fundação Santo André), Jan Vynckier(Valve (United States)), Philip Van Damme(Universitair Ziekenhuis Leuven), Annelies Vanhee, Guy Van den Abeele, Kathy de Koning, Nicolas Vandenbussche(Ghent University Hospital), Mariela Bettini, Caroline Schotte, Fanny O’Brien(Alexion Pharmaceuticals (United States)), Délphine Mahieu, Juliet Saba, Miguel Wilken, Bruno Bezerra Rosa, Thabata Veiga, Kenji P. Fujita, Gonzalo Vidal, Fábio Barroso(Université Paris-Sud), Rudy Mercelis, Hidekazu Suzuki(Kindai University Hospital), Tomihiro Imai(Sapporo Medical University Hospital), Pamela César, Ana Paula Souto Melo(University of Washington), Charlotte Smetcoren, Sarah Verjans, Petra Tilkin, Ann D’Hondt(KU Leuven), Olivier Stevens, Linda Wagemaekers, Igor Dias Brockhausen, Alejandra Dalila Garcia, Marcelo Rugiero, Rosana Rocha, Jan De Bleecker(Ghent University Hospital), Katrien De Mey, Claudio Mazia, Annelies Depreitere, Sien Van Daele, Daniel Ambrosio, Jingjing Wang(Ningxia University), Hirokazu Shiraishi(Nagasaki University Hospital), Yasushi Suzuki(Aichi Gakuin University), Akiyuki Uzawa(Chiba University), Marcelo Chaves, Meinoshin Okumura(Toneyama National Hospital)
Cited by 23
Related Papers
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|1.4k
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study
|The Lancet Neurology|2017|820
Interferon Regulatory Factor 6 ( <i>IRF6</i> ) Gene Variants and the Risk of Isolated Cleft Lip or Palate
|New England Journal of Medicine|2004|583
Burden of disease in Brazil, 1990–2016: a systematic subnational analysis for the Global Burden of Disease Study 2016
|The Lancet|2018|460
239th ENMC International Workshop: Classification of dermatomyositis, Amsterdam, the Netherlands, 14–16 December 2018
|Neuromuscular Disorders|2019|308